DRUG DESCRIPTION. LEVEMIRÂ® (insulin detemir [rDNA origin] injection) is a sterile solution of insulin detemir for use as a subcutaneous injection. Insulin detemir is a long-acting (up to 24-hour duration of action) recombinant human insulin analog. LEVEMIRÂ® is produced by a process that includes expression of recombinant DNA in Saccharomyces cerevisiae followed by chemical modification.
The UV Index is a linear scale, with higher values representing a greater risk of sunburn (which is correlated with other health risks) due to UV exposure. An index of 0 corresponds to zero UV radiation, as is essentially the case at night.
This can be divided into five regions in increasing order of wavelengths: 1  Ultraviolet C or (UVC) range, which spans a range of 100 to 280 nm. 2  Ultraviolet B or (UVB) range spans 280 to 315 nm. 3  Ultraviolet A or (UVA) spans 315 to 400 nm. 4  Visible range or light spans 380 to 780 nm. 5  Infrared range that spans 700 nm to 106 nm (1 mm).